Haleon announces Rs 2000 Cr investment to set up first manufacturing facility in India

June 08, 2026 | Monday | News

State-of-the-art greenfield facility will support Haleon's long-term growth plans in India

image credit- freepik

image credit- freepik

Haleon, a British healthcare company, has announced plans to establish its first manufacturing facility in India; a state-of-the-art greenfield site at Pithampur, Madhya Pradesh.

Spread across more than 40 acres in the Smart Industrial Park, the facility marks a significant investment in India’s consumer health sector and reinforces Haleon’s long-term commitment to the country as a strategic growth market.

The announcement was made in the presence of Dr Mohan Yadav, Chief Minister of Madhya Pradesh; Brian McNamara, Chief Executive Officer, Haleon; Kedar Lele, CEO India and President India Subcontinent, Haleon and Namrata Patel, Chief Supply Chain Officer, Haleon.

The new manufacturing site will serve as a key enabler for Haleon’s growth in India, strengthening supply chain resilience, driving domestic value addition, and supporting export to wider Asia.

Aligned with the Government’s ‘Make in India’ vision, the investment is expected to generate broad-based economic value over the next decade, enhancing export competitiveness, contributing to state revenues, and integrating India further into global supply chains.

The facility is projected to create up to 500 jobs, along with indirect employment opportunities, with a strong focus on leveraging skill development, local talent, and supplier ecosystems. Haleon also aims to build a diverse and inclusive workforce, including an ambition of up to 30% women employees at the site.

Announcing the investment, Brian McNamara, CEO, Haleon, said, “We aim to expand access to better everyday health for more than 300 million additional consumers in India. This will be key to achieving our broader ambition to reach one billion more consumers globally by 2030.”

The facility is designed on Haleon’s new global advance blueprint and is set to feature future-ready automated manufacturing capabilities. It is expected to be operational by 2029–30, enabling Haleon to meet growing demand across domestic and international markets.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

OR

Forgot your password?

OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy